Susan Moran serves as Executive at RayzeBio, Inc., where they oversee executive responsibilities. Since joining the company, Susan Moran has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jun 13, 2024 involved receiving (via award) 16,500 shares valued at $0.
Susan Moran currently holds 28,807 shares of RayzeBio, Inc. (RYZB), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Susan Moran has been a net neutral trader of RYZB stock. They have purchased $0 and sold $0 worth of shares.
Susan Moran's most recent insider trade was on Jun 13, 2024, when they sold 16,500 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $62.50 |
| Discretionary |
| Jan 22, 2024 | RYZB | $100.0K | Option Exercise | 30,875 | $3.24 | Discretionary |